(Q39694811)

14 September 2017

title

Perceived barriers to employment among persons living with HIV/AIDS. (English)

1 reference

14 September 2017

Brooks RA

1

1 reference

14 September 2017

Martin DJ

series ordinal

2

1 reference

14 September 2017

Ortiz DJ

series ordinal

3

1 reference

14 September 2017

Veniegas RC

series ordinal

4

1 reference

14 September 2017

publication date

1 August 2004

1 reference

14 September 2017

1 reference

14 September 2017

volume

16

1 reference

14 September 2017

issue

6

1 reference

14 September 2017

page(s)

756-766

1 reference

Consequences of Employment Protection? The Case of the Americans with Disabilities Act

14 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1080%2F09540120412331269594

Effect of employment on quality of life and psychological functioning in patients with HIV/AIDS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540120412331269594

Differences between employed and nonemployed dialysis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540120412331269594

Perception of quality of life of persons with HIV/AIDS and maintenance of nutritional parameters while on protease inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540120412331269594

Non-response bias in a study of cardiovascular diseases, functional status and self-rated health among elderly men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540120412331269594

Quality of life in asymptomatic- and symptomatic HIV infected patients in a trial of ritonavir/saquinavir therapy. The Prometheus Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540120412331269594

Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540120412331269594

Quality of life outcomes of combination zalcitabine-zidovudine, saquinavir-zidovudine, and saquinavir-zalcitabine-zidovudine therapy for HIV-infected adults with CD4 cell counts between 50 and 350 per cubic millimeter. PISCES (SV14604) Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540120412331269594

Selection bias due to non-response in a health survey among patients with rheumatoid arthritis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540120412331269594

Impact of HAART on causes of death of persons with late-stage AIDS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540120412331269594

Charges of human immunodeficiency virus discrimination in the workplace: the Americans with Disabilities Act in action

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540120412331269594

Employment, accommodation, finances and combination therapy: The social consequences of living with HIV/AIDS in Australia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540120412331269594

10.1080/09540120412331269594

21 January 2018

Identifiers

DOI

1 reference

14 September 2017

1 reference